The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Rimicorim 300mg Capsules



Brown & Burk IR LimitedPA23148/001/001

Main Information

Trade NameRimicorim 300mg Capsules
Active SubstancesLymecycline
Dosage FormCapsule, hard
Licence HolderBrown & Burk IR Limited
Licence NumberPA23148/001/001

Group Information

ATC CodeJ01AA Tetracyclines
J01AA04 lymecycline

Status

License statusAuthorised
Licence Issued05/04/2013
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back